Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Mosapride Citrate

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 376Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 4Gasmotin

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Gasmotin

    Mosapride Citrate

    arrow
    2024 ACI Convention
    Not Confirmed

    Brand Name : Gasmotin

    Japan
    arrow
    2024 ACI Convention
    Not Confirmed

    Dainippon Sumitomo

    Mosapride Citrate

    Main Therapeutic Indication : Gastrointestinal Disorders

    Currency : USD

    2016 Revenue in Millions : 59

    2015 Revenue in Millions : 82

    Growth (%) : -29

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Gasmotin

    Mosapride Citrate

    arrow
    2024 ACI Convention
    Not Confirmed

    Brand Name : Gasmotin

    Japan
    arrow
    2024 ACI Convention
    Not Confirmed

    Dainippon Sumitomo

    Mosapride Citrate

    Main Therapeutic Indication : Gastrointestinal Disorders

    Currency : USD

    2017 Revenue in Millions : 52

    2016 Revenue in Millions : 62

    Growth (%) : -17

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Gasmotin

    Mosapride Citrate

    arrow
    2024 ACI Convention
    Not Confirmed

    Brand Name : Gasmotin

    Japan
    arrow
    2024 ACI Convention
    Not Confirmed

    Dainippon Sumitomo

    Mosapride Citrate

    Main Therapeutic Indication : Gastrointestinal Disorders

    Currency : USD

    2018 Revenue in Millions : 35

    2017 Revenue in Millions : 44

    Growth (%) : -20%

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Gasmotin

    Mosapride Citrate

    arrow
    2024 ACI Convention
    Not Confirmed

    Brand Name : Gasmotin

    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed

    Dainippon Sumitomo

    Mosapride Citrate

    Main Therapeutic Indication : Gastrointestinal Disorders

    Currency : USD

    2019 Revenue in Millions : 30

    2018 Revenue in Millions : 36

    Growth (%) : -18

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF